Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FUWSB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,332
Award facts
- Contract value 100% obligated
- $18,332.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $18,332.43 delivery order for Dupixent 300 mg/2 ml pen (2 ml) on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic dermatitis, and asthma, making this delivery order part of the agency's pharmaceutical supply chain supporting military and federal healthcare systems.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen has established itself as a critical vendor for federal medical procurement through its competitive awards and capability to fulfill diverse pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FUWSB?
SPE2DB26FUWSB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FUWSB worth?
The government has obligated $18,332 on SPE2DB26FUWSB.
Is contract SPE2DB26FUWSB an order under another contract?
Yes. SPE2DB26FUWSB is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB26FUWSB competed?
The extent of competition for SPE2DB26FUWSB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award